Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma

Herbert H Loong1, Winnie Yeo1

  • 1Department of Clinical Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, State Key Laboratory in Oncology in South China, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong.

Insights

Novel microtubule-binding agents show promise for treating liver cancer. These agents, especially when combined with mammalian target of rapamycin inhibitors, may overcome resistance and improve outcomes for hepatocellular carcinoma.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Microtubules are crucial in mammalian cell division and are targets for anticancer drugs.
  • Microtubule-binding agents are established anticancer treatments, with newer agents offering improved specificity and resistance profiles.
  • Hepatocellular carcinoma (HCC) is challenging to treat, with limited efficacy of current chemotherapies.

Purpose of the Study:

  • To review recent advancements in novel microtubule-binding agents.
  • To discuss the potential efficacy of these agents in treating hepatocellular carcinoma.
  • To explore combination therapies, particularly with mammalian target of rapamycin inhibitors, for overcoming treatment resistance in HCC.

Main Methods:

  • Literature review of recent developments in microtubule-binding agents.
  • Analysis of preclinical data on the efficacy of these agents in hepatocellular carcinoma models.
  • Examination of studies investigating combination therapies for HCC treatment.

Main Results:

  • Newer anti-tubulin agents exhibit enhanced tumor specificity, reduced neurotoxicity, and overcome chemoresistance.
  • Preclinical evidence suggests microtubule-binding agents are effective against hepatocellular carcinoma.
  • Combination therapy with mammalian target of rapamycin inhibitors may overcome resistance to microtubule-binding agents in HCC.

Conclusions:

  • Novel microtubule-binding agents represent a promising therapeutic avenue for hepatocellular carcinoma.
  • Combination strategies involving microtubule-binding agents and mammalian target of rapamycin inhibitors warrant further investigation for HCC treatment.
  • These advancements offer potential for improved outcomes in difficult-to-treat liver cancers.

Related Concept Videos

Microtubules01:35

Microtubules

There are three types of cytoskeletal structures in eukaryotic cells—microfilaments, intermediate filaments, and microtubules. With a diameter of about 25 nm, microtubules are the thickest of these fibers. Microtubules carry out a variety of functions that include cell structure and support, transport of organelles, cell motility (movement), and the separation of chromosomes during cell division.
99.0K
Microtubules01:18

Microtubules

Microtubules are the thickest cytoskeletal filaments with a diameter of 25 nm. In prokaryotic organisms, microtubules are commonly found in locomotory appendages like cilia and flagella. In eukaryotic cells, microtubules form specialized extensions for moving fluid over the surface, like those found in cells lining the intestine.
Microtubules have two structurally similar globular protein subunits: α and β tubulins. In the cytosol, the α and β tubulins form a heterodimer....
10.7K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
6.2K
Microtubule Formation01:23

Microtubule Formation

Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation...
7.7K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.6K
Microtubules in Signaling01:22

Microtubules in Signaling

The primary cilium, made up of microtubules, acts as antennae on the cell surfaces for relaying external stimuli into the cells. These fine hair-like structures are present, generally one per cell. These are non-motile cilia in a 9+0 microtubules arrangement, where the central pair of microtubules are absent. The primary cilia arise from the basal body embedded in the cell membrane. Intraflagellar transport (IFT) carries requisite proteins from the cytoplasm to the cilium because the primary...
2.2K